Sagespring Wealth Partners LLC Makes New $1.46 Million Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Sagespring Wealth Partners LLC acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,793 shares of the medical equipment provider’s stock, valued at approximately $1,458,000.

Several other institutional investors have also recently modified their holdings of the company. Vanguard Group Inc. raised its stake in shares of Intuitive Surgical by 1.1% during the 4th quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider’s stock valued at $16,813,478,000 after buying an additional 360,591 shares during the last quarter. Geode Capital Management LLC raised its position in Intuitive Surgical by 3.2% during the fourth quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider’s stock valued at $4,039,200,000 after acquiring an additional 243,802 shares in the last quarter. Fisher Asset Management LLC lifted its holdings in Intuitive Surgical by 1.8% in the fourth quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider’s stock valued at $2,541,356,000 after acquiring an additional 86,488 shares during the period. Norges Bank purchased a new stake in Intuitive Surgical in the 4th quarter worth approximately $2,401,493,000. Finally, Invesco Ltd. grew its stake in shares of Intuitive Surgical by 7.7% during the 4th quarter. Invesco Ltd. now owns 4,148,180 shares of the medical equipment provider’s stock worth $2,165,184,000 after purchasing an additional 295,025 shares during the period. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

ISRG has been the subject of several analyst reports. Raymond James boosted their target price on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. UBS Group increased their target price on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research note on Monday, January 27th. Evercore ISI lifted their price target on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Erste Group Bank downgraded Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Monday, March 17th. Finally, Wells Fargo & Company boosted their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $611.86.

Intuitive Surgical Price Performance

ISRG opened at $493.60 on Monday. The firm has a market capitalization of $175.81 billion, a price-to-earnings ratio of 77.00, a price-to-earnings-growth ratio of 5.85 and a beta of 1.55. The company’s 50 day simple moving average is $532.72 and its two-hundred day simple moving average is $532.68. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00.

Insider Activity at Intuitive Surgical

In related news, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now directly owns 12,275 shares in the company, valued at approximately $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Robert Desantis sold 11,545 shares of the stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the transaction, the executive vice president now owns 5,224 shares of the company’s stock, valued at $2,607,925.28. The trade was a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 33,754 shares of company stock valued at $17,691,621. 0.70% of the stock is currently owned by insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.